← 產業報告目錄

Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-11-25頁數 606報告編號 MD4362

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The veterinary reference laboratory market is forecasted to grow from USD 4.75 million in 2025 to USD 6.46 million by 2030, recording a CAGR of 6.3%. The increasing prevalence of zoonotic and chronic animal diseases, rising companion animal ownership, and the growing emphasis on preventive healthcare primarily drive market expansion. The rising demand for advanced diagnostic testing, including molecular diagnostics, immunodiagnostics, and clinical chemistry, has accelerated the establishment of high-throughput reference laboratories in both developed and emerging regions. Moreover, technological advancements in automation, AI-based image analysis, and molecular testing are enabling faster turnaround times and improved diagnostic accuracy, fostering greater trust among veterinarians and pet owners. At the same time, the increasing integration of diagnostic services with digital platforms and laboratory information management systems (LIMS) is streamlining workflows, enhancing sample traceability, and enabling remote access to test results. The rising focus on early disease detection and companion animal wellness programs further supports test adoption, while expanding veterinary corporatization and partnerships between clinics and reference labs are driving consistent sample inflows. However, the market faces challenges such as high operational and testing costs, a shortage of skilled laboratory professionals, and stringent regulatory standards governing veterinary diagnostics. Additionally, maintaining quality assurance across diverse geographies and addressing biosecurity and sample transport challenges remain key priorities for laboratories aiming to sustain accuracy, reliability, and growth momentum. The clinical pathology segment accounted for the largest share of the market, by application, in 2024. Based on application, the veterinary reference laboratory market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. In 2024, clinical pathology accounted for the largest share of the market. This dominance is attributed to the segment’s critical role in delivering detailed diagnostic insights through hematology, cytology, and clinical chemistry testing. These analyses enable veterinarians to accurately diagnose systemic disorders, track therapeutic progress, and effectively manage complex disease conditions. The rising companion animal population and increasing frequency of veterinary consultations have fueled the demand for routine pathology services. Moreover, technological advancements in automated analyzers and digital pathology systems have significantly improved diagnostic precision, efficiency, and turnaround time, further driving market growth in this segment. The veterinary clinics & hospitals segment is expected to dominate the market, by end user, during the forecast period. Based on end user, the veterinary reference laboratory market is segmented into veterinary clinics and hospitals, research institutes and universities, point-of-care/in-house labs, and other end users. In 2024, veterinary clinics and hospitals accounted for the largest share of the global market. This dominance is primarily driven by the rising volume of diagnostic testing conducted through referral partnerships with centralized laboratories, as clinics increasingly outsource advanced and specialized tests such as molecular diagnostics, immunodiagnostics, and clinical chemistry to improve diagnostic accuracy and efficiency. The growing companion animal population, higher pet healthcare expenditure, and expanding network of small and large veterinary practices have further contributed to the rising sample inflow from clinics and hospitals. These facilities rely on reference laboratories for confirmatory and complex testing that cannot be efficiently performed in-house, thereby enhancing treatment outcomes and operational workflows. Additionally, the integration of digital sample management systems and automated result reporting between clinics and reference labs is improving turnaround times and supporting evidence-based veterinary care. In 2024, North America dominated the veterinary reference laboratory market. The veterinary reference laboratory market is segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. In 2024, North America accounted for the largest share of the global market. This dominance can be attributed to several key factors, including the high prevalence of companion animal ownership, strong awareness of preventive veterinary care, and significant healthcare expenditure on pets across the region. The presence of leading industry players such as IDEXX Laboratories, Zoetis Services LLC, and Mars, Incorporated, coupled with a well-established network of veterinary hospitals and diagnostic centers, has further reinforced the region’s leadership. Within North America, the United States held the largest market share, supported by the country’s advanced veterinary infrastructure, growing demand for specialized and molecular diagnostic testing, and rapid adoption of automation and digital pathology solutions. Additionally, the U.S. market benefits from favorable pet insurance penetration, a robust ecosystem of veterinary service providers, and strong investment in R&D for companion and livestock diagnostic innovations. Breakdown of supply-side primary interviews: • By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%) • By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%) • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%) Breakdown of demand-side primary interviews: • By Company Type: Veterinary Clinics & Hospitals (70%), POC/In-house labs (15%), Research Institutions and Universities (10%), and Other End Users (5%) • By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%) • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%) Research Coverage This report studies the veterinary reference laboratory market based on service, application, animal type, end user, and region. It also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the market's opportunities and challenges and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six main regions and respective countries. Reasons to Buy the Report The report can help established companies and new or smaller firms understand market trends, which will help them capture a larger market share. Firms that purchase the report can utilize one or more of the five strategies mentioned below. This report provides insights into the following points: • Analysis of key drivers, opportunities, restraints, and challenges influencing the growth of the veterinary reference laboratory market. • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and service launches in the veterinary reference laboratory market • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary reference laboratory services across regions. • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary reference laboratory market. • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary reference laboratory market.
目錄 Table of Contents
1 INTRODUCTION 48 1.1 STUDY OBJECTIVES 48 1.2 MARKET DEFINITION 48 1.3 STUDY SCOPE 48 1.3.1 MARKET SEGMENTATION 49 1.3.2 REGIONAL SCOPE 50 1.3.3 INCLUSIONS & EXCLUSIONS 50 1.3.4 YEARS CONSIDERED 51 1.4 MARKET STAKEHOLDERS 51 1.5 SUMMARY OF CHANGES 52 2 RESEARCH METHODOLOGY 54 2.1 RESEARCH DATA 54 2.2 RESEARCH METHODOLOGY DESIGN 54 2.2.1 SECONDARY DATA 55 2.2.1.1 Key sources of secondary research 55 2.2.1.2 Key objectives of secondary research 56 2.2.1.3 Key data from secondary sources 57 2.2.2 PRIMARY DATA 57 2.2.2.1 Key primary sources 58 2.2.2.2 Key objectives of primary research 58 2.2.2.3 Key data from primary sources 59 2.2.2.4 Key industry insights 60 2.3 MARKET SIZE ESTIMATION 62 2.3.1 REVENUE SHARE ANALYSIS 62 2.3.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 64 2.3.3 DEMAND-SIDE ANALYSIS 64 2.3.4 TOP-DOWN APPROACH 65 2.3.5 BOTTOM-UP APPROACH 66 2.4 DATA TRIANGULATION 68 2.5 MARKET SHARE ANALYSIS 69 2.6 STUDY ASSUMPTIONS 70 2.6.1 MARKET ASSUMPTIONS 70 2.6.2 GROWTH RATE ASSUMPTIONS 70 2.7 RISK ANALYSIS 71 2.8 RESEARCH LIMITATIONS 71 2.8.1 METHODOLOGY-RELATED LIMITATIONS 71 2.8.2 SCOPE-RELATED LIMITATIONS 71 3 EXECUTIVE SUMMARY 72 4 PREMIUM INSIGHTS 78 4.1 VETERINARY REFERENCE LABORATORY MARKET OVERVIEW 78 4.2 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY PRODUCT AND COUNTRY (2024) 79 4.3 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL MIX 80 4.4 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 80 4.5 VETERINARY REFERENCE LABORATORY MARKET: DEVELOPED VS. EMERGING ECONOMIES 81 5 MARKET OVERVIEW 82 5.1 MARKET DYNAMICS 83 5.1.1 DRIVERS 83 5.1.1.1 Growing routine wellness and oncology screening in companion animals 83 5.1.1.2 Rapid adoption of digital pathology and telepathology 84 5.1.1.3 Increasing prevalence/awareness of zoonotic and emerging diseases 85 5.1.1.4 Growth in companion animal population 87 5.1.1.5 Rising demand for animal-derived food products 90 5.1.1.6 Increasing demand for pet insurance and growing animal health expenditure 90 5.1.2 RESTRAINTS 92 5.1.2.1 Competition from in-clinic and point-of-care testing 92 5.1.2.2 High capital investment and fixed cost burden in veterinary reference laboratories 92 5.1.3 OPPORTUNITIES 93 5.1.3.1 Potential growth opportunities in emerging economies 93 5.1.3.2 Investment in advanced technologies in veterinary reference laboratories 94 5.1.4 CHALLENGES 95 5.1.4.1 Competitive pressure and margin pressure in veterinary reference laboratories 95 5.1.4.2 Data privacy, biosecurity, and sample ownership in veterinary reference laboratories 95 5.2 INDUSTRY TRENDS 96 5.2.1 DIGITAL PATHOLOGY, TELECYTOLOGY, AND AI FROM PILOT TO COMMERCIAL SERVICES 96 5.2.2 CONTINUED CONSOLIDATION AND VERTICAL INTEGRATION ACROSS ANIMAL-HEALTH ECOSYSTEM 97 5.3 TECHNOLOGY ANALYSIS 97 5.3.1 KEY TECHNOLOGIES 97 5.3.1.1 Real-time PCR/Quantitative PCR (qPCR) and digital PCR (dPCR) 97 5.3.1.2 Next-generation/Metagenomic sequencing (NGS/mNGS) 98 5.3.1.3 CRISPR-based diagnostics 99 5.3.2 ADJACENT TECHNOLOGIES 99 5.3.2.1 Integrated LIMS and one health surveillance platforms 99 5.3.2.2 AI-driven diagnostic tools 100 5.3.3 COMPLEMENTARY TECHNOLOGIES 100 5.3.3.1 Telepathology 100 5.3.3.2 Breath and saliva-based diagnostic tools 101 5.4 PORTER’S FIVE FORCES ANALYSIS 102 5.4.1 THREAT OF NEW ENTRANTS 103 5.4.2 THREAT OF SUBSTITUTES 103 5.4.3 BARGAINING POWER OF SUPPLIERS 103 5.4.4 BARGAINING POWER OF BUYERS 104 5.4.5 INTENSITY OF COMPETITIVE RIVALRY 104 5.5 KEY STAKEHOLDERS & BUYING CRITERIA 105 5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS 105 5.5.2 KEY BUYING CRITERIA 106 5.6 REGULATORY ANALYSIS 107 5.6.1 REGULATORY LANDSCAPE 107 5.6.1.1 North America 107 5.6.1.1.1 US 107 5.6.1.2 Europe 108 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108 5.7 PATENT ANALYSIS 111 5.7.1 PATENT PUBLICATION TRENDS FOR VETERINARY REFERENCE LABORATORY 111 5.7.2 JURISDICTION & TOP APPLICANT ANALYSIS 112 5.7.3 MAJOR PATENTS 113 5.8 PRICING ANALYSIS 115 5.8.1 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022−2024 115 5.8.2 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022–2024 117 5.9 REIMBURSEMENT ANALYSIS 119 5.10 PET PARENT BEHAVIOUR 120 5.11 KEY CONFERENCES & EVENTS, 2025–2026 122 5.12 END-USER PERSPECTIVE & UNMET NEEDS 123 5.13 IMPACT OF AI/GEN AI ON VETERINARY REFERENCE LABORATORY MARKET 124 5.13.1 INTRODUCTION 124 5.13.2 MARKET POTENTIAL IN VETERINARY REFERENCE LABORATORY ECOSYSTEM 124 5.13.3 AI-USE CASES 125 5.13.4 KEY COMPANIES IMPLEMENTING AI 125 5.14 ECOSYSTEM MAP 126 5.15 ROLE IN ECOSYSTEM 127 5.16 VALUE CHAIN ANALYSIS 128 5.17 INVESTMENT & FUNDING SCENARIO 130 5.18 CASE STUDY ANALYSIS 131 5.18.1 DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES 131 5.18.2 IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING 132 5.18.3 VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW 133 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 134 5.20 IMPACT OF 2025 US TARIFF ON VETERINARY REFERENCE LABORATORY MARKET 134 5.20.1 INTRODUCTION 134 5.20.2 KEY TARIFF RATES 136 5.20.3 PRICE IMPACT ANALYSIS 137 5.20.4 IMPACT ON COUNTRY/REGION 138 5.20.4.1 North America 138 5.20.4.2 Europe 138 5.20.4.3 Asia Pacific 139 5.20.4.4 Latin America 139 5.20.5 IMPACT ON END-USE INDUSTRIES 139 5.20.5.1 Veterinary hospitals & clinics 139 5.20.5.2 Point-of-care (POC) and in-house testing setups 140 5.20.5.3 Veterinary research institutes & universities 140 5.20.5.4 Other end users 140 6 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE 141 6.1 INTRODUCTION 142 6.2 CLINICAL CHEMISTRY 143 6.2.1 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE 145 6.2.1.1 Companion animals 145 6.2.1.1.1 Rising pet ownership and preventive health trends to drive segment growth 145 6.2.1.2 Livestock animals 147 6.2.1.2.1 Rising focus on herd health, food safety, and export compliance to strengthen segment growth 147 6.3 IMMUNODIAGNOSTICS 149 6.3.1 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE 152 6.3.1.1 ELISA 152 6.3.1.1.1 ELISA tests to dominate immunodiagnostics segment owing to widespread use in infectious disease detection 152 6.3.2 LATERAL FLOW ASSAYS 154 6.3.2.1 Technological advancements and cost-effectiveness to aid market growth 154 6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 156 6.3.3.1 Rising prevalence of atopic disorders and adoption of precision allergy testing to augment market growth 156 6.3.4 OTHER IMMUNODIAGNOSTIC SERVICES 158 6.3.5 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE 160 6.3.5.1 Companion animals 160 6.3.5.1.1 High pet care spending and preventive diagnostics to propel market growth 160 6.3.5.2 Livestock animals 162 6.3.5.2.1 Regulatory compliance, food safety, and disease surveillance to sustain steady demand 162 6.4 MOLECULAR DIAGNOSTICS 164 6.4.1 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE 167 6.4.2 PCR TESTS 167 6.4.2.1 High sensitivity and diagnostic accuracy to drive dominance of PCR tests 167 6.4.3 MICROARRAYS 169 6.4.3.1 Advancements in genetic profiling and pharmacogenomics to expand microarray applications 169 6.4.4 NUCLEIC ACID SEQUENCING 171 6.4.4.1 Rising adoption of next-generation sequencing and precision genomics to fuel market growth 171 6.4.5 OTHER MOLECULAR DIAGNOSTIC SERVICES 173 6.4.6 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE 175 6.4.6.1 Companion animals 175 6.4.6.1.1 High pet-owner spending, precision diagnostics, and rapid turnaround to drive dominance 175 6.4.6.2 Livestock animals 177 6.4.6.2.1 Regulatory mandates, disease surveillance, and one health initiatives to strengthen market presence 177 6.5 HEMATOLOGY 179 6.5.1 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE 181 6.5.1.1 Companion animals 181 6.5.1.1.1 High diagnostic frequency and technological advancements TO sustain segment growth 181 6.5.1.2 Livestock animals 183 6.5.1.2.1 Rising focus on herd health, biosecurity, and productivity optimization to drive steady market growth 183   6.6 URINALYSIS 185 6.6.1 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE 187 6.6.1.1 Companion animals 187 6.6.1.1.1 Rising incidences of renal diseases in companion animals to drive market 187 6.6.1.2 Livestock animals 189 6.6.1.2.1 Growing emphasis on metabolic profiling and precision herd management to strengthen livestock urinalysis segment 189 6.7 HISTOPATHOLOGY & CYTOLOGY 191 6.7.1 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE 193 6.7.1.1 Companion animals 193 6.7.1.1.1 Clinical reliance on laboratory-based tissue and cellular diagnostics for definitive case management to drive market 193 6.7.1.2 Livestock animals 195 6.7.1.2.1 Biosecurity investments and disease surveillance programs to drive steady demand 195 6.8 MICROBIOLOGY 197 6.8.1 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE 199 6.8.1.1 Companion animals 199 6.8.1.1.1 Rising AMR awareness and shift toward rapid and automated testing to spur market growth 199 6.8.1.2 Livestock animals 201 6.8.1.2.1 Antimicrobial resistance monitoring and food safety compliance to sustain demand 201 6.9 OTHER SERVICES 203 6.9.1 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY ANIMAL TYPE 205 6.9.1.1 Companion animals 205 6.9.1.2 Livestock animals 207 7 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION 209 7.1 INTRODUCTION 210 7.2 CLINICAL PATHOLOGY 210 7.2.1 INCREASING AWARENESS OF ANIMAL HEALTH TO DRIVE MARKET 210 7.3 BACTERIOLOGY 213 7.3.1 GROWTH IN VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET 213 7.4 VIROLOGY 215 7.4.1 EMERGING INFECTIOUS DISEASES IN ANIMALS TO PROPEL MARKET GROWTH 215 7.5 PARASITOLOGY 217 7.5.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO AUGMENT MARKET GROWTH 217   7.6 PRODUCTIVITY TESTING 219 7.6.1 EXPANSION OF LIVESTOCK INDUSTRIES TO SUPPORT MARKET GROWTH 219 7.7 PREGNANCY TESTING 221 7.7.1 ADVANCED BREEDING TECHNIQUES AND RESPONSIBLE PET OWNERSHIP TO DRIVE MARKET GROWTH 221 7.8 TOXICOLOGY TESTING 223 7.8.1 GLOBALIZATION OF FOOD SUPPLY CHAINS TO PROPEL MARKET GROWTH 223 7.9 OTHER APPLICATIONS 225 8 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE 227 8.1 INTRODUCTION 228 8.2 COMPANION ANIMALS 228 8.2.1 DOGS 232 8.2.1.1 High insurance coverage and availability of reimbursements to drive market 232 8.2.2 CATS 234 8.2.2.1 Increasing pet cat population to support market uptake 234 8.2.3 HORSES 236 8.2.3.1 Growing awareness regarding equine health to fuel market growth 236 8.2.4 OTHER COMPANION ANIMALS 239 8.3 LIVESTOCK ANIMALS 240 8.3.1 CATTLE 244 8.3.1.1 Growing consumption of dairy products to drive market growth 244 8.3.2 SWINE 246 8.3.2.1 Increasing incidence of infectious diseases to fuel market growth 246 8.3.3 POULTRY 248 8.3.3.1 Increasing demand for poultry meat to spur market growth 248 8.3.4 SHEEP & GOATS 250 8.3.4.1 International trade and strict health regulations to drive market 250 8.3.5 OTHER LIVESTOCK ANIMALS 252 9 VETERINARY REFERENCE LABORATORY MARKET, BY END USER 254 9.1 INTRODUCTION 255 9.2 VETERINARY HOSPITALS & CLINICS 255 9.2.1 RISING PET OWNERSHIP AND GROWING DIAGNOSTIC AWARENESS TO DRIVE DEMAND FOR VETERINARY REFERENCE LABS 255 9.3 POINT-OF-CARE/IN-HOUSE TESTING 258 9.3.1 INCREASING COLLABORATIONS BETWEEN IN-HOUSE DIAGNOSTIC SETUPS AND REFERENCE LABORATORIES TO AID MARKET GROWTH 258 9.4 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES 260 9.4.1 INCREASING ACADEMIC COLLABORATIONS AND FUNDING TO DRIVE UTILIZATION OF REFERENCE LABORATORY SERVICES 260 9.5 OTHER END USERS 262 10 VETERINARY REFERENCE LABORATORY MARKET, BY REGION 264 10.1 INTRODUCTION 265 10.2 NORTH AMERICA 266 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 266 10.2.2 US 274 10.2.2.1 US to dominate Norths American veterinary reference laboratory market during forecast period 274 10.2.3 CANADA 281 10.2.3.1 Growing pet adoption, rising animal healthcare expenditure, and increasing number of veterinary practices to drive market 281 10.3 EUROPE 288 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 289 10.3.2 GERMANY 296 10.3.2.1 Increasing pet healthcare expenditure and rising demand for animal-derived food products to aid market growth 296 10.3.3 UK 303 10.3.3.1 Increased pet ownership and availability of animal health insurance policies to augment market growth 303 10.3.4 FRANCE 310 10.3.4.1 Growth of livestock industry and high companion animal population to support market growth 310 10.3.5 ITALY 317 10.3.5.1 Rising awareness about pet healthcare to drive market 317 10.3.6 SPAIN 324 10.3.6.1 Growing demand for pig and poultry products to drive market 324 10.3.7 NETHERLANDS 331 10.3.7.1 Increasing animal healthcare expenditure to drive market growth 331 10.3.8 REST OF EUROPE 338 10.4 ASIA PACIFIC 345 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 345 10.4.2 CHINA 353 10.4.2.1 Large pool of food-producing animals to drive market 353 10.4.3 JAPAN 360 10.4.3.1 Awareness about zoonotic diseases and increased pet expenditure to propel market growth 360 10.4.4 INDIA 368 10.4.4.1 Growing demand for livestock products and increasing awareness about animal health to support market growth 368 10.4.5 AUSTRALIA 376 10.4.5.1 Increasing investments in pet services and products to aid market growth 376 10.4.6 SOUTH KOREA 383 10.4.6.1 Increasing pet population in urban households to drive market 383   10.4.7 THAILAND 390 10.4.7.1 Rapidly expanding companion animal population to create higher demand for advanced diagnostic testing 390 10.4.8 NEW ZEALAND 397 10.4.8.1 Increased demand for preventive care and high aging pet population to drive market growth 397 10.4.9 REST OF ASIA PACIFIC 404 10.5 LATIN AMERICA 411 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 412 10.5.2 BRAZIL 419 10.5.2.1 Increasing use of reproductive technologies in livestock industry to propel market growth 419 10.5.3 MEXICO 426 10.5.3.1 Increasing adoption of advanced diagnostic technologies to propel market growth 426 10.5.4 ARGENTINA 433 10.5.4.1 Focus on advanced healthcare and regular disease monitoring among companion animals to drive market 433 10.5.5 REST OF LATIN AMERICA 440 10.6 MIDDLE EAST & AFRICA 447 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 448 10.6.2 GCC COUNTRIES 455 10.6.2.1 Kingdom of Saudi Arabia 462 10.6.2.1.1 Technology advancements in veterinary diagnostics to boost market growth 462 10.6.2.2 UAE 469 10.6.2.2.1 Government support and favorable initiatives to fuel market growth 469 10.6.2.3 Rest of GCC Countries 476 10.6.3 REST OF MIDDLE EAST & AFRICA 482 11 COMPETITIVE LANDSCAPE 490 11.1 INTRODUCTION 490 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 490 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET 490 11.3 REVENUE ANALYSIS, 2020−2024 493 11.4 MARKET SHARE ANALYSIS, 2024 494 11.4.1 RANKING OF KEY MARKET PLAYERS 494 11.4.2 GLOBAL MARKET SHARE ANALYSIS 495 11.4.3 US MARKET SHARE ANALYSIS 497   11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 498 11.5.1 STARS 498 11.5.2 EMERGING LEADERS 498 11.5.3 PERVASIVE PLAYERS 498 11.5.4 PARTICIPANTS 498 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 500 11.5.5.1 Company footprint 500 11.5.5.2 Region footprint 501 11.5.5.3 Service footprint 502 11.5.5.4 Animal type footprint 503 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 504 11.6.1 PROGRESSIVE COMPANIES 504 11.6.2 RESPONSIVE COMPANIES 504 11.6.3 DYNAMIC COMPANIES 504 11.6.4 STARTING BLOCKS 504 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SME PLAYERS, 2024 506 11.6.5.1 Detailed list of key startups/SME players 506 11.6.5.2 Competitive benchmarking of key emerging players/startups 507 11.7 BRAND/PRODUCT COMPARISON 508 11.8 R&D EXPENDITURE OF KEY PLAYERS 509 11.9 COMPANY VALUATION & FINANCIAL METRICS 509 11.9.1 FINANCIAL METRICS 509 11.9.2 COMPANY VALUATION 510 11.10 COMPETITIVE SCENARIO 510 11.10.1 SERVICE LAUNCHES & ENHANCEMENTS 510 11.10.2 DEALS 512 11.10.3 EXPANSIONS 513 11.10.4 OTHER DEVELOPMENTS 514 12 COMPANY PROFILES 515 12.1 KEY PLAYERS 515 12.1.1 IDEXX LABORATORIES, INC. 515 12.1.1.1 Business overview 515 12.1.1.2 Services offered 517 12.1.1.3 Recent developments 520 12.1.1.3.1 Service launches and enhancements 520 12.1.1.4 MnM view 521 12.1.1.4.1 Key strengths 521 12.1.1.4.2 Strategic choices 522 12.1.1.4.3 Weaknesses & competitive threats 522   12.1.2 MARS, INCORPORATED 523 12.1.2.1 Business overview 523 12.1.2.2 Services offered 524 12.1.2.3 Recent developments 526 12.1.2.3.1 Service launches 526 12.1.2.3.2 Deals 526 12.1.2.3.3 Expansions 527 12.1.2.4 MnM view 527 12.1.2.4.1 Key strengths 527 12.1.2.4.2 Strategic choices 527 12.1.2.4.3 Weaknesses & competitive threats 528 12.1.3 ZOETIS SERVICES LLC 529 12.1.3.1 Business overview 529 12.1.3.2 Services offered 531 12.1.3.3 Recent developments 533 12.1.3.3.1 Deals 533 12.1.3.3.2 Expansions 534 12.1.3.4 MnM view 534 12.1.3.4.1 Key strengths 534 12.1.3.4.2 Strategic choices 535 12.1.3.4.3 Weaknesses & competitive threats 535 12.1.4 GD (ROYAL GD ANIMAL HEALTH) 536 12.1.4.1 Business overview 536 12.1.4.2 Services offered 537 12.1.4.3 Recent developments 543 12.1.4.3.1 Service launches 543 12.1.4.3.2 Deals 544 12.1.4.3.3 Expansions 545 12.1.4.4 MnM view 545 12.1.4.4.1 Key strengths 545 12.1.4.4.2 Strategic choices 546 12.1.4.4.3 Weaknesses & competitive threats 546 12.1.5 LABOKLIN GMBH & CO. KG 547 12.1.5.1 Business overview 547 12.1.5.2 Services offered 547 12.1.5.3 Recent developments 549 12.1.5.3.1 Service launches 549 12.1.5.4 MnM view 550 12.1.5.4.1 Key strengths 550 12.1.5.4.2 Strategic choices 550 12.1.5.4.3 Weaknesses & competitive threats 550   12.1.6 CVS (UK) LIMITED 551 12.1.6.1 Business overview 551 12.1.6.2 Services offered 553 12.1.6.3 Recent developments 556 12.1.6.3.1 Service launches 556 12.1.7 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS 557 12.1.7.1 Business overview 557 12.1.7.2 Services offered 557 12.1.8 ANIMAL AND PLANT HEALTH AGENCY 559 12.1.8.1 Business overview 559 12.1.8.2 Services offered 559 12.1.8.3 Recent developments 561 12.1.8.3.1 Other developments 561 12.1.9 ICAR–NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS) 562 12.1.9.1 Business overview 562 12.1.9.2 Services offered 562 12.1.10 NATIONAL VETERINARY SERVICES 564 12.1.10.1 Business overview 564 12.1.10.2 Services offered 565 12.1.10.3 Recent developments 566 12.1.10.3.1 Expansions 566 12.1.10.3.2 Other developments 567 12.1.11 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL) 568 12.1.11.1 Business overview 568 12.1.11.2 Services offered 568 12.1.11.3 Recent developments 569 12.1.11.3.1 Service launches and enhancements 569 12.1.12 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY 571 12.1.12.1 Business overview 571 12.1.12.2 Services offered 571 12.1.12.3 Recent developments 573 12.1.12.3.1 Service launches 573 12.1.12.3.2 Expansions 574 12.1.13 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY) 575 12.1.13.1 Business overview 575 12.1.13.2 Services offered 575 12.1.14 BIOBEST LABORATORIES LTD. 578 12.1.14.1 Business overview 578 12.1.14.2 Services offered 579 12.1.14.3 Recent developments 581 12.1.14.3.1 Expansions 581 12.1.15 PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE 582 12.1.15.1 Business overview 582 12.1.15.2 Services offered 582 12.2 OTHER PLAYERS 584 12.2.1 ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON 584 12.2.2 UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY 585 12.2.3 VAXXINOVA 586 12.2.4 MIRA VISTA LABS 588 12.2.5 ELLIE DIAGNOSTICS 589 12.2.6 PROTATEK INTERNATIONAL, INC. 590 12.2.7 THE PIRBRIGHT INSTITUTE 591 12.2.8 CVR LABORATORY (CVRL) 592 12.2.9 VETERINARY PATHOLOGY GROUP 593 12.2.10 FRIEDRICH-LOEFFLER-INSTITUT (FLI) 594 13 APPENDIX 595 13.1 DISCUSSION GUIDE 595 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 601 13.3 CUSTOMIZATION OPTIONS 603 13.3.1 SERVICE ANALYSIS 603 13.3.2 COMPANY INFORMATION 603 13.3.3 GEOGRAPHIC ANALYSIS 603 13.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 603 13.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT 603 13.3.6 BY SERVICE MARKET SHARE ANALYSIS (TOP 5 PLAYERS) 603 13.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 603 13.4 RELATED REPORTS 604 13.5 AUTHOR DETAILS 605
圖表清單 List of Tables & Figures
TABLE 1 VETERINARY REFERENCE LABORATORY MARKET: INCLUSIONS & EXCLUSIONS 50 TABLE 2 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 51 TABLE 3 VETERINARY REFERENCE LABORATORY MARKET: MARKET ASSUMPTIONS 70 TABLE 4 VETERINARY REFERENCE LABORATORY MARKET: RISK ANALYSIS 71 TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES, 2009–2023 86 TABLE 6 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS) 88 TABLE 7 US: AVERAGE PREMIUMS PAID, 2020 VS. 2023 90 TABLE 8 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2023 (USD MILLION) 91 TABLE 9 VETERINARY REFERENCE LABORATORY MARKET: PORTER’S FIVE FORCES 102 TABLE 10 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORY PRODUCTS (%) 105 TABLE 11 KEY BUYING CRITERIA FOR TOP THREE END USERS 107 TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108 TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 15 MAJOR PATENTS IN VETERINARY REFERENCE LABORATORY MARKET 113 TABLE 16 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022–2024 (USD) 115 TABLE 17 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY SERVICES, BY REGION, 2022–2024 (USD) 117 TABLE 18 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022–2024 (USD) 118 TABLE 19 AVERAGE SELLING PRICE TREND OF MOLECULAR DIAGNOSTIC SERVICES, BY REGION, 2022–2024 (USD) 118 TABLE 20 AVERAGE SELLING PRICE TREND OF HAEMATOLOGY SERVICES, BY REGION, 2022–2024 (USD) 118 TABLE 21 AVERAGE SELLING PRICE TREND OF HISTOPATHOLOGY &CYTOLOGY SERVICES, BY REGION, 2022–2024 (USD) 119 TABLE 22 AVERAGE SELLING PRICE TREND OF URINALYSIS SERVICES, BY REGION, 2022–2024 (USD) 119 TABLE 23 KEY CONFERENCES & EVENTS IN VETERINARY REFERENCE LABORATORY MARKET, JANUARY 2025–DECEMBER 2026 122 TABLE 24 KEY COMPANIES IMPLEMENTING AI IN VETERINARY REFERENCE LABORATORY MARKET 126 TABLE 25 VETERINARY REFERENCE LABORATORY PROVIDERS: ROLE IN ECOSYSTEM 127 TABLE 26 CASE STUDY 1: DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES 131 TABLE 27 CASE STUDY 2: IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING 132 TABLE 28 CASE STUDY 3: VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW 133 TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES 136 TABLE 30 KEY PRODUCT-RELATED TARIFF EFFECTIVE VETERINARY REFERENCE LABORATORY 136 TABLE 31 IMPACT OF US TARIFF ON CANADA 138 TABLE 32 IMPACT OF US TARIFF ON GERMANY AND UK 138 TABLE 33 IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA 139 TABLE 34 IMPACT OF US TARIFF ON MEXICO 139 TABLE 35 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 142 TABLE 36 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY SERVICES 143 TABLE 37 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 38 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 145 TABLE 39 CLINICAL CHEMISTRY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 40 CLINICAL CHEMISTRY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 41 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES 150 TABLE 42 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 43 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 152 TABLE 44 IMMUNODIAGNOSTICS MARKET FOR ELISA, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 45 IMMUNODIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 46 IMMUNODIAGNOSTICS MARKET FOR ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 47 OTHER IMMUNODIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 48 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE , 2023–2030 (USD MILLION) 160 TABLE 49 IMMUNODIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 50 IMMUNODIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 51 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC SERVICES 165 TABLE 52 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 53 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 167 TABLE 54 MOLECULAR DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 55 MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 56 MOLECULAR DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 57 OTHER MOLECULAR DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 58 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 175 TABLE 59 MOLECULAR DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 60 MOLECULAR DIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 61 KEY PLAYERS PROVIDING HAEMATOLOGY SERVICES 179 TABLE 62 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 63 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 181 TABLE 64 HAEMATOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 65 HAEMATOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 66 KEY PLAYERS PROVIDING URINALYSIS TECHNOLOGIES 185 TABLE 67 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 68 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 187 TABLE 69 URINALYSIS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 70 URINALYSIS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 71 KEY PLAYERS PROVIDING HISTOPATHOLOGY & CYTOLOGY SERVICES 191 TABLE 72 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 73 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 193 TABLE 74 HISTOPATHOLOGY & CYTOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 75 HISTOPATHOLOGY & CYTOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 76 KEY PLAYERS PROVIDING MICROBIOLOGY SERVICES 197 TABLE 77 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 78 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 199 TABLE 79 MICROBIOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 80 MICROBIOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 81 KEY PLAYERS PROVIDING OTHER VETERINARY REFERENCE LABORATORY SERVICES 203 TABLE 82 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 83 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 205 TABLE 84 OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 85 OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 86 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 210 TABLE 87 KEY PLAYERS PROVIDING CLINICAL PATHOLOGY SERVICES 211 TABLE 88 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 89 KEY PLAYERS PROVIDING BACTERIOLOGY SERVICES 213 TABLE 90 VETERINARY REFERENCE LABORATORY MARKET FOR BACTERIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 91 KEY PLAYERS PROVIDING VIROLOGY SERVICES 215 TABLE 92 VETERINARY REFERENCE LABORATORY MARKET FOR VIROLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 93 KEY PLAYERS PROVIDING PARASITOLOGY SERVICES 217 TABLE 94 VETERINARY REFERENCE LABORATORY MARKET FOR PARASITOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 95 KEY PLAYERS PROVIDING PRODUCTIVITY TESTING SERVICES 219 TABLE 96 VETERINARY REFERENCE LABORATORY MARKET FOR PRODUCTIVITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 97 KEY PLAYERS PROVIDING PREGNANCY TESTING SERVICES 221 TABLE 98 VETERINARY REFERENCE LABORATORY MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 99 KEY PLAYERS PROVIDING TOXICOLOGY TESTING SERVICES 223 TABLE 100 VETERINARY REFERENCE LABORATORY MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 101 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 102 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 228 TABLE 103 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR COMPANION ANIMALS 229 TABLE 104 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 105 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 106 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR DOGS 232 TABLE 107 VETERINARY REFERENCE LABORATORY MARKET FOR DOGS, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 108 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR CATS 234 TABLE 109 VETERINARY REFERENCE LABORATORY MARKET FOR CATS, BY COUNTRY, 2023–2030 (USD MILLION) 235 TABLE 110 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR HORSES 236 TABLE 111 VETERINARY REFERENCE LABORATORY MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 112 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 113 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR LIVESTOCK ANIMALS 240 TABLE 114 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 115 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 116 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR CATTLE 244 TABLE 117 VETERINARY REFERENCE LABORATORY MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 118 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR SWINE 246 TABLE 119 VETERINARY REFERENCE LABORATORY MARKET FOR SWINE, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 120 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR POULTRY 248 TABLE 121 VETERINARY REFERENCE LABORATORY MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 122 VETERINARY REFERENCE LABORATORY MARKET FOR SHEEP & GOATS, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 123 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 124 VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 255 TABLE 125 US: BASIC ANNUAL EXPENSES FOR CATS AND DOGS, 2023 (USD) 256 TABLE 126 VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY HOSPITALS & CLINICS BY COUNTRY, 2023–2030 (USD MILLION) 257 TABLE 127 VETERINARY REFERENCE LABORATORY MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 128 VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION) 261 TABLE 129 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 263 TABLE 130 VETERINARY REFERENCE LABORATORY MARKET, BY REGION, 2023–2030 (USD MILLION) 266 TABLE 131 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 268 TABLE 132 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 268 TABLE 133 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 269 TABLE 134 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 269 TABLE 135 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 269 TABLE 136 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 270 TABLE 137 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 270 TABLE 138 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 270 TABLE 139 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 271 TABLE 140 NORTH AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 271 TABLE 141 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 271 TABLE 142 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 272 TABLE 143 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 272 TABLE 144 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 273 TABLE 145 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 146 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 147 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 274 TABLE 148 US: KEY MACROINDICATORS 275 TABLE 149 US: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 275 TABLE 150 US: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 276 TABLE 151 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 276 TABLE 152 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 276 TABLE 153 US: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 277 TABLE 154 US: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 277 TABLE 155 US: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 277 TABLE 156 US: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 278 TABLE 157 US: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 278 TABLE 158 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 278 TABLE 159 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 279 TABLE 160 US: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 279 TABLE 161 US: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 280 TABLE 162 US: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 163 US: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 164 US: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 281 TABLE 165 CANADA: KEY MACROINDICATORS 282 TABLE 166 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 282 TABLE 167 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 283 TABLE 168 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 283 TABLE 169 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 283 TABLE 170 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 284 TABLE 171 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 284 TABLE 172 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 284 TABLE 173 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 285 TABLE 174 CANADA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 285 TABLE 175 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 285 TABLE 176 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 286 TABLE 177 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 286 TABLE 178 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 287 TABLE 179 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 180 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 181 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 288 TABLE 182 EUROPE: COMPANION POPULATION, BY COUNTRY, 2023 (MILLION) 289 TABLE 183 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 290 TABLE 184 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 290 TABLE 185 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 291 TABLE 186 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 291 TABLE 187 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 291 TABLE 188 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 292 TABLE 189 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 292 TABLE 190 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 292 TABLE 191 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 293 TABLE 192 EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 293 TABLE 193 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 293 TABLE 194 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 294 TABLE 195 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 294 TABLE 196 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 295 TABLE 197 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 198 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 199 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 296 TABLE 200 GERMANY: KEY MACROINDICATORS 297 TABLE 201 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 297 TABLE 202 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 297 TABLE 203 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 298 TABLE 204 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 298 TABLE 205 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 298 TABLE 206 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 299 TABLE 207 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 299 TABLE 208 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 299 TABLE 209 GERMANY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 300 TABLE 210 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 300 TABLE 211 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 300 TABLE 212 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 301 TABLE 213 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 301 TABLE 214 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 215 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 216 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 303 TABLE 217 UK: KEY MACROINDICATORS 304 TABLE 218 UK: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 304 TABLE 219 UK: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 305 TABLE 220 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 305 TABLE 221 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 305 TABLE 222 UK: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 306 TABLE 223 UK: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 306 TABLE 224 UK: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 306 TABLE 225 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 307 TABLE 226 UK: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 307 TABLE 227 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 307 TABLE 228 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 308 TABLE 229 UK: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 308 TABLE 230 UK: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 309 TABLE 231 UK: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 232 UK: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 233 UK: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 310 TABLE 234 FRANCE: KEY MACROINDICATORS 310 TABLE 235 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 311 TABLE 236 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 311 TABLE 237 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 312 TABLE 238 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 312 TABLE 239 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 312 TABLE 240 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 313 TABLE 241 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 313 TABLE 242 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 313 TABLE 243 RANCE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 314 TABLE 244 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 314 TABLE 245 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 314 TABLE 246 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 315 TABLE 247 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 315 TABLE 248 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 249 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 250 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 317 TABLE 251 ITALY: KEY MACROINDICATORS 317 TABLE 252 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 318 TABLE 253 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 318 TABLE 254 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 319 TABLE 255 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 319 TABLE 256 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 319 TABLE 257 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 320 TABLE 258 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 320 TABLE 259 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 320 TABLE 260 ITALY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 321 TABLE 261 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 321 TABLE 262 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 321 TABLE 263 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 322 TABLE 264 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 322 TABLE 265 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 266 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 267 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 324 TABLE 268 SPAIN: KEY MACROINDICATORS 325 TABLE 269 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 325 TABLE 270 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 326 TABLE 271 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 326 TABLE 272 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 326 TABLE 273 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 327 TABLE 274 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 327 TABLE 275 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 327 TABLE 276 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 328 TABLE 277 SPAIN: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 328 TABLE 278 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 328 TABLE 279 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 329 TABLE 280 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 329 TABLE 281 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 330 TABLE 282 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 283 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 284 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 331 TABLE 285 NETHERLANDS: KEY MACROINDICATORS 331 TABLE 286 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 332 TABLE 287 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 332 TABLE 288 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 333 TABLE 289 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 333 TABLE 290 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 333 TABLE 291 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 334 TABLE 292 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 334 TABLE 293 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 334 TABLE 294 NETHERLANDS: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 335 TABLE 295 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 335 TABLE 296 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 335 TABLE 297 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 336 TABLE 298 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 336 TABLE 299 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 300 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 301 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 338 TABLE 302 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 339 TABLE 303 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 339 TABLE 304 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 340 TABLE 305 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 340 TABLE 306 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 340 TABLE 307 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 341 TABLE 308 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 341 TABLE 309 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 341 TABLE 310 REST OF EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 342 TABLE 311 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 342 TABLE 312 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 342 TABLE 313 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 343 TABLE 314 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 343 TABLE 315 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 316 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 317 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 345 TABLE 318 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 347 TABLE 319 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 347 TABLE 320 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 348 TABLE 321 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 348 TABLE 322 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 348 TABLE 323 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 349 TABLE 324 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 349 TABLE 325 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 349 TABLE 326 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 350 TABLE 327 ASIA PACIFIC: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 350 TABLE 328 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 350 TABLE 329 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 351 TABLE 330 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 351 TABLE 331 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 352 TABLE 332 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 333 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 334 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 353 TABLE 335 CHINA: KEY MACROINDICATORS 354 TABLE 336 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 354 TABLE 337 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 355 TABLE 338 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 355 TABLE 339 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 355 TABLE 340 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 356 TABLE 341 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 356 TABLE 342 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 356 TABLE 343 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 357 TABLE 344 CHINA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 357 TABLE 345 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 357 TABLE 346 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 358 TABLE 347 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 358 TABLE 348 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 359 TABLE 349 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 350 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 351 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 360 TABLE 352 JAPAN: PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 361 TABLE 353 JAPAN: KEY MACROINDICATORS 361 TABLE 354 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 362 TABLE 355 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 362 TABLE 356 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 363 TABLE 357 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 363 TABLE 358 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 363 TABLE 359 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 364 TABLE 360 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 364 TABLE 361 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 364 TABLE 362 JAPAN: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 365 TABLE 363 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 365 TABLE 364 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 365 TABLE 365 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 366 TABLE 366 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 366 TABLE 367 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 368 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 369 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 368 TABLE 370 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 369 TABLE 371 INDIA: KEY MACROINDICATORS 369 TABLE 372 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 370 TABLE 373 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 370 TABLE 374 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 371 TABLE 375 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 371 TABLE 376 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 371 TABLE 377 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 372 TABLE 378 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 372 TABLE 379 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 372 TABLE 380 INDIA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 373 TABLE 381 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 373 TABLE 382 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 373 TABLE 383 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 374 TABLE 384 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 374 TABLE 385 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 386 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 387 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 376 TABLE 388 AUSTRALIA: KEY MACROINDICATORS 377 TABLE 389 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 377 TABLE 390 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 378 TABLE 391 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 378 TABLE 392 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 378 TABLE 393 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 379 TABLE 394 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 379 TABLE 395 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 379 TABLE 396 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 380 TABLE 397 AUSTRALIA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 380 TABLE 398 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 380 TABLE 399 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 381 TABLE 400 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 381 TABLE 401 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 382 TABLE 402 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 403 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 404 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 383 TABLE 405 SOUTH KOREA: KEY MACROINDICATORS 383 TABLE 406 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 384 TABLE 407 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 384 TABLE 408 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 385 TABLE 409 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 385 TABLE 410 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 385 TABLE 411 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 386 TABLE 412 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 386 TABLE 413 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 386 TABLE 414 SOUTH KOREA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 387 TABLE 415 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 387 TABLE 416 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 387 TABLE 417 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 388 TABLE 418 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 388 TABLE 419 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 420 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 421 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 390 TABLE 422 THAILAND: KEY MACROINDICATORS 391 TABLE 423 THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 391 TABLE 424 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 392 TABLE 425 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 392 TABLE 426 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 392 TABLE 427 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 393 TABLE 428 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 393 TABLE 429 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 393 TABLE 430 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 394 TABLE 431 THAILAND: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 394 TABLE 432 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 394 TABLE 433 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 395 TABLE 434 THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 395 TABLE 435 THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 396 TABLE 436 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 396 TABLE 437 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 396 TABLE 438 THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 397 TABLE 439 NEW ZEALAND: KEY MACROINDICATORS 398 TABLE 440 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 398 TABLE 441 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 399 TABLE 442 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 399 TABLE 443 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 399 TABLE 444 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 400 TABLE 445 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 400 TABLE 446 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 400 TABLE 447 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 401 TABLE 448 NEW ZEALAND: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 401 TABLE 449 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 401 TABLE 450 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 402 TABLE 451 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 402 TABLE 452 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 403 TABLE 453 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 403 TABLE 454 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 403 TABLE 455 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 404 TABLE 456 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 405 TABLE 457 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 405 TABLE 458 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 406 TABLE 459 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 406 TABLE 460 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 406 TABLE 461 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 407 TABLE 462 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 407 TABLE 463 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 407 TABLE 464 REST OF ASIA PACIFIC: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 408 TABLE 465 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 408 TABLE 466 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 408 TABLE 467 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 409 TABLE 468 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 409 TABLE 469 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 410 TABLE 470 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 410 TABLE 471 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 411 TABLE 472 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 412 TABLE 473 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 413 TABLE 474 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 413 TABLE 475 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 414 TABLE 476 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 414 TABLE 477 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 414 TABLE 478 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 415 TABLE 479 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 415 TABLE 480 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 415 TABLE 481 LATIN AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 416 TABLE 482 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 416 TABLE 483 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 416 TABLE 484 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 417 TABLE 485 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 417 TABLE 486 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 418 TABLE 487 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 418 TABLE 488 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 419 TABLE 489 BRAZIL: KEY MACROINDICATORS 420 TABLE 490 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 420 TABLE 491 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 420 TABLE 492 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 421 TABLE 493 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 421 TABLE 494 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 421 TABLE 495 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 422 TABLE 496 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 422 TABLE 497 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 422 TABLE 498 BRAZIL: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 423 TABLE 499 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 423 TABLE 500 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 423 TABLE 501 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 424 TABLE 502 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 424 TABLE 503 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 504 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 505 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 426 TABLE 506 MEXICO: KEY MACROINDICATORS 427 TABLE 507 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 427 TABLE 508 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 427 TABLE 509 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 428 TABLE 510 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 428 TABLE 511 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 428 TABLE 512 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 429 TABLE 513 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 429 TABLE 514 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 429 TABLE 515 MEXICO: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 430 TABLE 516 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 430 TABLE 517 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 430 TABLE 518 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 431 TABLE 519 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 431 TABLE 520 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 521 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 522 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 433 TABLE 523 ARGENTINA: KEY MACROINDICATORS 434 TABLE 524 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 434 TABLE 525 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 434 TABLE 526 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 435 TABLE 527 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 435 TABLE 528 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 435 TABLE 529 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 436 TABLE 530 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 436 TABLE 531 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 436 TABLE 532 ARGENTINA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 437 TABLE 533 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 437 TABLE 534 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 437 TABLE 535 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 438 TABLE 536 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 438 TABLE 537 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 439 TABLE 538 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 439 TABLE 539 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 440 TABLE 540 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 441 TABLE 541 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 441 TABLE 542 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 442 TABLE 543 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 442 TABLE 544 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 442 TABLE 545 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 443 TABLE 546 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 443 TABLE 547 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 443 TABLE 548 REST OF LATIN AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 444 TABLE 549 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 444 TABLE 550 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 445 TABLE 551 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 445 TABLE 552 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 446 TABLE 553 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 446 TABLE 554 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 446 TABLE 555 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 447 TABLE 556 MIDDLE EAST & ARICA: VETERINARY REFERENCE LABORATORY MARKET, BY REGION, 2023–2030 (USD MILLION) 448 TABLE 557 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 449 TABLE 558 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 449 TABLE 559 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 450 TABLE 560 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 450 TABLE 561 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 450 TABLE 562 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 451 TABLE 563 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 451 TABLE 564 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 451 TABLE 565 MIDDLE EAST & AFRICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 452 TABLE 566 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 452 TABLE 567 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 452 TABLE 568 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 453 TABLE 569 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 453 TABLE 570 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 454 TABLE 571 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 454 TABLE 572 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 455 TABLE 573 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 456 TABLE 574 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 456 TABLE 575 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 457 TABLE 576 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 457 TABLE 577 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 457 TABLE 578 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 458 TABLE 579 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 458 TABLE 580 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 458 TABLE 581 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 459 TABLE 582 GCC COUNTRIES: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 459 TABLE 583 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 459 TABLE 584 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 460 TABLE 585 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 460 TABLE 586 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 461 TABLE 587 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 461 TABLE 588 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 461 TABLE 589 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 462 TABLE 590 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS 462 TABLE 591 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 463 TABLE 592 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 463 TABLE 593 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 464 TABLE 594 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 464 TABLE 595 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 464 TABLE 596 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 465 TABLE 597 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 465 TABLE 598 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 465 TABLE 599 KINGDOM OF SAUDI ARABIA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 466 TABLE 600 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 466 TABLE 601 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 466 TABLE 602 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 467 TABLE 603 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 467 TABLE 604 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 605 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 606 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 469 TABLE 607 UAE: KEY MACROINDICATORS 469 TABLE 608 UAE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 470 TABLE 609 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 470 TABLE 610 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 470 TABLE 611 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 471 TABLE 612 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 471 TABLE 613 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 471 TABLE 614 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 472 TABLE 615 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 472 TABLE 616 UAE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 472 TABLE 617 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 473 TABLE 618 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 473 TABLE 619 UAE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 474 TABLE 620 UAE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 474 TABLE 621 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 475 TABLE 622 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 475 TABLE 623 UAE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 476 TABLE 624 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 476 TABLE 625 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 477 TABLE 626 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 477 TABLE 627 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 477 TABLE 628 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 478 TABLE 629 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 478 TABLE 630 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 478 TABLE 631 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 479 TABLE 632 REST OF GCC COUNTRIES: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 479 TABLE 633 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 479 TABLE 634 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 480 TABLE 635 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 480 TABLE 636 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 481 TABLE 637 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 481 TABLE 638 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 481 TABLE 639 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 482 TABLE 640 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 483 TABLE 641 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 483 TABLE 642 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 484 TABLE 643 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 484 TABLE 644 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 484 TABLE 645 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 485 TABLE 646 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 485 TABLE 647 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 485 TABLE 648 REST OF MIDDLE EAST & AFRICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 486 TABLE 649 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 486 TABLE 650 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 486 TABLE 651 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 487 TABLE 652 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 487 TABLE 653 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 488 TABLE 654 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 488 TABLE 655 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 489 TABLE 656 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET 490 TABLE 657 GLOBAL VETERINARY REFERENCE LABORATORY MARKET: DEGREE OF COMPETITION 496 TABLE 658 US VETERINARY REFERENCE LABORATORY MARKET: DEGREE OF COMPETITION 497 TABLE 659 VETERINARY REFERENCE LABORATORY MARKET: REGION FOOTPRINT 501 TABLE 660 VETERINARY REFERENCE LABORATORY MARKET: SERVICE FOOTPRINT 502 TABLE 661 VETERINARY REFERENCE LABORATORY MARKET: ANIMAL TYPE FOOTPRINT 503 TABLE 662 VETERINARY REFERENCE LABORATORY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 506 TABLE 663 VETERINARY REFERENCE LABORATORY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT AND REGION 507 TABLE 664 VETERINARY REFERENCE LABORATORY MARKET: SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2022−SEPTEMBER 2025 510 TABLE 665 VETERINARY REFERENCE LABORATORY MARKET: DEALS, JANUARY 2022−SEPTEMBER 2025 512 TABLE 666 VETERINARY REFERENCE LABORATORY MARKET: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 513 TABLE 667 VETERINARY REFERENCE LABORATORY MARKET: OTHER DEVELOPMENTS, JANUARY 2022−SEPTEMBER 2025 514 TABLE 668 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 515 TABLE 669 IDEXX LABORATORIES, INC.: SERVICES OFFERED 517 TABLE 670 IDEXX LABORATORIES, INC.: SERVICE LAUNCHES AND ENHANCEMENTS, JANUARY 2022−SEPTEMBER 2025 520 TABLE 671 MARS, INCORPORATED: COMPANY OVERVIEW 523 TABLE 672 MARS, INCORPORATED: SERVICES OFFERED 524 TABLE 673 MARS, INCORPORATED: SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025 526 TABLE 674 MARS, INCORPORATED: DEALS, JANUARY 2022−SEPTEMBER 2025 526 TABLE 675 MARS, INCORPORATED: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 527 TABLE 676 ZOETIS SERVICES LLC: COMPANY OVERVIEW 529 TABLE 677 ZOETIS SERVICES LLC: SERVICES OFFERED 531 TABLE 678 ZOETIS SERVICES LLC: DEALS, JANUARY 2022−SEPTEMBER 2025 533 TABLE 679 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 534 TABLE 680 GD (ROYAL GD ANIMAL HEALTH): COMPANY OVERVIEW 536 TABLE 681 GD (ROYAL GD ANIMAL HEALTH): SERVICES OFFERED 537 TABLE 682 GD (ROYAL GD ANIMAL HEALTH): SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025 543 TABLE 683 GD (ROYAL GD ANIMAL HEALTH): DEALS, JANUARY 2022−SEPTEMBER 2025 544 TABLE 684 GD (ROYAL GD ANIMAL HEALTH): EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 545 TABLE 685 LABOKLIN GMBH & CO. KG: COMPANY OVERVIEW 547 TABLE 686 LABOKLIN GMBH & CO. KG: SERVICES OFFERED 547 TABLE 687 LABOKLIN GMBH & CO. KG: SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025 549 TABLE 688 CVS (UK) LIMITED: COMPANY OVERVIEW 551 TABLE 689 CVS (UK) LIMITED: SERVICES OFFERED 553 TABLE 690 CVS (UK) LIMITED: SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025 556 TABLE 691 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS: COMPANY OVERVIEW 557 TABLE 692 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS: SERVICES OFFERED 557 TABLE 693 ANIMAL AND PLANT HEALTH AGENCY: COMPANY OVERVIEW 559 TABLE 694 ANIMAL AND PLANT HEALTH AGENCY: SERVICES OFFERED 559 TABLE 695 ANIMAL AND PLANT HEALTH AGENCY: OTHER DEVELOPMENTS, JANUARY 2022−SEPTEMBER 2025 561 TABLE 696 ICAR–NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS): COMPANY OVERVIEW 562 TABLE 697 ICAR–NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS): SERVICES OFFERED 562 TABLE 698 NATIONAL VETERINARY SERVICES: COMPANY OVERVIEW 564 TABLE 699 NATIONAL VETERINARY SERVICES: SERVICES OFFERED 565 TABLE 700 NATIONAL VETERINARY SERVICES: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 566 TABLE 701 NATIONAL VETERINARY SERVICES: OTHER DEVELOPMENTS, JANUARY 2022−SEPTEMBER 2025 567 TABLE 702 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL): COMPANY OVERVIEW 568 TABLE 703 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL): SERVICES OFFERED 568 TABLE 704 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL): SERVICE LAUNCHES AND ENHANCEMENTS, JANUARY 2022−SEPTEMBER 2025 569 TABLE 705 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: COMPANY OVERVIEW 571 TABLE 706 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: SERVICES OFFERED 571 TABLE 707 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: SERVICE LAUNCHES, JANUARY 2022−SEPTEMBER 2025 573 TABLE 708 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 574 TABLE 709 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY): COMPANY OVERVIEW 575 TABLE 710 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY): PRODUCTS/SERVICES OFFERED 575 TABLE 711 BIOBEST LABORATORIES LTD.: COMPANY OVERVIEW 578 TABLE 712 BIOBEST LABORATORIES LTD.: SERVICES OFFERED 579 TABLE 713 BIOBEST LABORATORIES LTD.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 581 TABLE 714 PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE: COMPANY OVERVIEW 582 TABLE 715 PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE: SERVICES OFFERED 582 TABLE 716 ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON: COMPANY OVERVIEW 584 TABLE 717 UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY: COMPANY OVERVIEW 585 TABLE 718 VAXXINOVA: COMPANY OVERVIEW 586 TABLE 719 MIRA VISTA LABS: COMPANY OVERVIEW 588 TABLE 720 ELLIE DIAGNOSTICS: COMPANY OVERVIEW 589 TABLE 721 PROTATEK INTERNATIONAL, INC.: COMPANY OVERVIEW 590 TABLE 722 THE PIRBRIGHT INSTITUTE: COMPANY OVERVIEW 591 TABLE 723 CVR LABORATORY (CVRL): COMPANY OVERVIEW 592 TABLE 724 VETERINARY PATHOLOGY GROUP: COMPANY OVERVIEW 593 TABLE 725 FRIEDRICH-LOEFFLER-INSTITUT (FLI): COMPANY OVERVIEW 594 FIGURE 1 VETERINARY REFERENCE LABORATORY MARKET SEGMENTATION 49 FIGURE 2 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL SCOPE 50 FIGURE 3 VETERINARY REFERENCE LABORATORY MARKET: YEARS CONSIDERED 51 FIGURE 4 VETERINARY REFERENCE LABORATORY MARKET: RESEARCH DESIGN 54 FIGURE 5 VETERINARY REFERENCE LABORATORY MARKET: KEY DATA FROM SECONDARY SOURCES 57 FIGURE 6 VETERINARY REFERENCE LABORATORY MARKET: KEY PRIMARY SOURCES 58 FIGURE 7 VETERINARY REFERENCE LABORATORY MARKET: KEY DATA FROM PRIMARY SOURCES 59 FIGURE 8 VETERINARY REFERENCE LABORATORY MARKET: KEY INDUSTRY INSIGHTS 60 FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 60 FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 61 FIGURE 11 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 61 FIGURE 12 VETERINARY REFERENCE LABORATORY MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 62 FIGURE 13 VETERINARY REFERENCE LABORATORY MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR IDEXX LABORATORIES, INC. (2024) 63 FIGURE 14 REVENUE ANALYSIS OF TOP FIVE COMPANIES IN VETERINARY REFERENCE LABORATORY MARKET (2024) 63 FIGURE 15 VETERINARY DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS 65 FIGURE 16 VETERINARY REFERENCE LABORATORY MARKET: TOP-DOWN APPROACH 65 FIGURE 17 VETERINARY REFERENCE LABORATORY MARKET: BOTTOM-UP APPROACH 66 FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VETERINARY REFERENCE LABORATORY MARKET (2025–2030) 67 FIGURE 19 VETERINARY REFERENCE LABORATORY MARKET: CAGR PROJECTIONS 67 FIGURE 20 VETERINARY REFERENCE LABORATORY MARKET: DATA TRIANGULATION METHODOLOGY 69 FIGURE 21 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2025 VS. 2030 (USD MILLION) 73 FIGURE 22 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 74 FIGURE 23 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION) 74 FIGURE 24 COMPANION ANIMALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 75 FIGURE 25 LIVESTOCK ANIMALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 76 FIGURE 26 VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 76 FIGURE 27 GEOGRAPHIC SNAPSHOT OF VETERINARY REFERENCE LABORATORY MARKET 77 FIGURE 28 INCREASING INCIDENCE OF CHRONIC CONDITIONS TO FUEL MARKET GROWTH 78 FIGURE 29 CHINA AND CONSUMABLES COMMANDED LARGEST MARKET SHARE IN 2024 79 FIGURE 30 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 80 FIGURE 31 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD 80 FIGURE 32 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES FROM 2025 TO 2030 81 FIGURE 33 VETERINARY REFERENCE LABORATORY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 83 FIGURE 34 EUROPE: PET POPULATION (DOGS VS. CATS), 2021–2023 (MILLION) 89 FIGURE 35 US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD) 91 FIGURE 36 VETERINARY REFERENCE LABORATORY MARKET: PORTER’S FIVE FORCES ANALYSIS 102 FIGURE 37 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORIES 105 FIGURE 38 KEY BUYING CRITERIA FOR TOP THREE END USERS 106 FIGURE 39 NUMBER OF GRANTED PATENT APPLICATIONS IN VETERINARY REFERENCE LABORATORY MARKET (JANUARY 2014–SEPTEMBER 2025) 112 FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY REFERENCE LABORATORY PATENTS (JANUARY 2014–OCTOBER 2025) 113 FIGURE 41 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC AND URINALYSIS SERVICES, BY KEY PLAYER (2024) 116 FIGURE 42 AVERAGE SELLING PRICE OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION (2024) 117 FIGURE 43 AI-USE CASES IN VETERINARY REFERENCE LABORATORY MARKET 125 FIGURE 44 VETERINARY REFERENCE LABORATORY MARKET: ECOSYSTEM MAP 127 FIGURE 45 VETERINARY REFERENCE LABORATORY MARKET: VALUE CHAIN ANALYSIS 129 FIGURE 46 FUNDING AND NUMBER OF DEALS IN VETERINARY REFERENCE LABORATORY MARKET, 2020-2024 (USD MILLION) 131 FIGURE 47 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ CUSTOMERS IN VETERINARY REFERENCE LABORATORY MARKET 134 FIGURE 48 ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, DEVELOPING VS. DEVELOPED COUNTRIES, 2020–2030 242 FIGURE 49 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC SNAPSHOT 265 FIGURE 50 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT 267 FIGURE 51 US: POPULATION OF DOGS, 2012–2022 (MILLION) 274 FIGURE 52 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT 346 FIGURE 53 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET (2020−2024) 493 FIGURE 54 RANKING OF KEY PLAYERS IN GLOBAL VETERINARY SOFTWARE MARKET, 2024 494 FIGURE 55 GLOBAL VETERINARY REFERENCE LABORATORY MARKET SHARE ANALYSIS (2024) 496 FIGURE 56 US: VETERINARY REFERENCE LABORATORY MARKET SHARE ANALYSIS, BY KEY PLAYER (2024) 497 FIGURE 57 VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 499 FIGURE 58 VETERINARY REFERENCE LABORATORY MARKET: COMPANY FOOTPRINT 500 FIGURE 59 VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 505 FIGURE 60 VETERINARY REFERENCE LABORATORY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 508 FIGURE 61 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET, 2022−2024 509 FIGURE 62 EV/EBITDA OF KEY VENDORS 509 FIGURE 63 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 510 FIGURE 64 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT 516 FIGURE 65 ZOETIS SERVICES LLC: COMPANY SNAPSHOT 530 FIGURE 66 CVS (UK) LIMITED: COMPANY SNAPSHOT 552

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們